|会社名||Rockwell Medical Inc （ロックウェル・メディカル）|
|分野（sector）||Health Care ヘルスケア|
|産業（industry）||Biotechnology: Electromedical_Electrotherapeutic Apparatus|
|業種||医薬品 医療関連（Health Care）|
|概要||事業概要 ロックウェル・メディカル(Rockwell Medical Inc)は鉄欠乏症、二次性副甲状腺機能亢進症および血液透析治療のための製品およびサービスを提供する末期腎疾患（ESRD）および慢性腎疾患（CKD）を対象とするバイオ医薬品企業である。同社は血液透析市場を通じ、血液透析製品を医薬品、透析濃縮物、透析キット、透析プロセスで使用されるその他の補助製品などの製造、販売、流通に従事する。同社の医薬品には、トリフェリック（ピロリン酸第二鉄クエン酸）およびカルシトリオール（アクティブビタミンD）注射が含まれる。トリフェリック（Triferic）は、血液透析患者に透析液を介して送達される鉄化合物で、透析治療中に生じる鉄損失を置き換える。カルシトリオール（活性型ビタミンD）注射は透析患者における二次性副甲状腺機能亢進症の治療のために使用される。 ロックウェル・メディカルは米国の血液透析治療関連会社。腎不全や慢性腎臓病治療用の透析溶液や補助製品の製造、販売に従事。主な製品は｢CitraPure Citric-Acid Concentrate｣、｢Dri-Sate Dry Acid｣、｢Renal Pure Liquid Acid Concentrate｣などがある。 Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The Company's initial focus is the treatment of anemia in end-stage kidney disease (ESKD). Rockwell Medical's exclusive renal drug therapies, Triferic (ferric pyrophosphate citrate) Dialysate and Triferic AVNU (ferric pyrophosphate citrate injection), are the only FDA-approved therapeutics indicated for iron replacement and maintenance of hemoglobin in hemodialysis patients. Rockwell Medical is also an established manufacturer, supplier and leader in delivering high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad.|
|本社所在地||30142 Wixom Road Wixom MI 48393 USA|
|代表者氏名||Benjamin Wolin ベンジャミン・ワリン|
|代表者役職名||Chairman of the Board 取締役会会長|
|市場名||NASDAQ National Market System|
|決算概要||決算概要 BRIEF: For the six months ended 30 June 2018 Rockwell Medical Inc revenues increased 7% to $29.9M. Net loss increased 50% to $17.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and Product Development increase of 12% to $3.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.23 to -$0.35.|
Rocking stocks: Vislink Technologies, Inc. (NASDAQ:VISL 0.00%), Rockwell Medical, Inc. (NASDAQ:RMTI 2.37%) 2021/09/26 23:26:47 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Rocking stocks: Vislink Technologies, Inc. (NASDAQ:VISL 0.00%), Rockwell Medical, Inc. (NASDAQ:RMTI 2.37%) appeared first on Stocks Equity .
Fascinating stocks: Elys Game Technology, Corp. (NASDAQ:ELYS 3.43%), Rockwell Medical, Inc. (NASDAQ:RMTI -1.56%) 2021/09/22 22:57:01 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Fascinating stocks: Elys Game Technology, Corp. (NASDAQ:ELYS 3.43%), Rockwell Medical, Inc. (NASDAQ:RMTI -1.56%) appeared first on Stocks Equity .
Hemodialysis Powder Solution Market Growth, Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis And Forecasts 2029 Baxter, Rockwell Medical, Fresenius 2021/09/10 13:37:25 OpenPR
The research study presented here is an intelligent take on the global Hemodialysis Powder Solution Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of
Waging stocks: Ambev S.A. (NYSE:ABEV -1.56%), Rockwell Medical, Inc. (NASDAQ:RMTI -1.73%) 2021/09/09 23:49:36 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Waging stocks: Ambev S.A. (NYSE:ABEV -1.56%), Rockwell Medical, Inc. (NASDAQ:RMTI -1.73%) appeared first on Stocks Equity .
Rockwell Medical Extends Distribution Agreement with Nipro 2021/06/14 12:07:25 Smarter Analyst
Rockwell Medical Technologies (RMTI) renewed its distribution agreement with Nipro Medical for another three years. Rockwell Medical focuses on the development and commercialization The post Rockwell Medical Extends Distribution Agreement with Nipro appeared first on Smarter Analyst .
Rockwell Medical gains on extending distribution agreement with Nipro Medical for dialysis concentrates 2021/06/11 16:45:52 Seeking Alpha
Rockwell Medical Announces Extension of Multi-Year Distribution Agreement with Nipro Medical Corporation for Dialysis Concentrates 2021/06/11 16:20:00 Intrado Digital Media
Provides for minimum of approximately $11.4M in purchases over 3-year Period Provides for minimum of approximately $11.4M in purchases over 3-year Period
Rockwell Medical pops 6% on licensing deal for Triferic AVNU in Turkey 2021/06/08 11:18:00 Seeking Alpha
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic in Turkey 2021/06/08 11:00:00 Wallstreet:Online
- With approximately 65,000 patients receiving hemodialysis annually, Turkey represents a significant and expanding market opportunity - WIXOM, Mich. and ANKARA, Turkey, June 08, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around
Why Rockwell Medical's Stock Is Trading Higher Today 2021/02/09 20:17:01 Benzinga
Rockwell Medical (NASDAQ: RMTI ) shares are trading higher … Full story available on Benzinga.com
Global Haemodialysis Concentrates Market ||Key play Baxter International Inc., Nipro Corporation, Rockwell Medical Inc., Cantel Medical Corp., Guangdong Biolight Meditech Co. Ltd., Treet Corp. Ltd., and Sopharma AD.ers 2021/02/08 12:05:46 OpenPR
Global haemodialysis concentrates market report published by Prophecy Market Insights offers holistic view of various influencing factors and aims to answer all the target market related questions. Download Free sample copy of this report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/2240 The research scope provides comprehensive market size,
Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd. - Stocks News Feed 2021/02/01 12:00:00 Stocks News Feed
WIXOM, Mich., Feb. 01, 2021 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency anemia management, today announced that its partner in South Korea, Jeil Pharmaceutical Co., Ltd., filed New Drug Applications (NDA) with the Ministry of Food and Drug Safety (MFDS)… Read More »Rockwell Medical Announces Submission of Triferic® New Drug Application in South Korea by Partner, Jeil Pharmaceutical Co., Ltd.
Rockwell Medical (NASDAQ:RMTI) Stock Rating Upgraded by ValuEngine 2020/11/20 08:18:41 Transcript Daily
ValuEngine upgraded shares of Rockwell Medical (NASDAQ:RMTI) from a hold rating to a buy rating in a research report sent to investors on Monday morning, ValuEngine reports. Separately, Zacks Investment Research raised shares of Rockwell Medical from a sell rating to a buy rating and set a $1.75 price objective on the stock in a […]
The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure 2020/11/03 12:38:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 2) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Immunovant Inc (NASDAQ: IMVT ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 2) AEterna Zentaris Inc. (NASDAQ: AEZS ) Aikido Pharma Inc (NASDAQ: AIKI ) Artelo Biosciences Inc (NASDAQ: ARTL ) Avita Therapeutics Inc (NASDAQ: RCEL ) Benitec Biopharma Inc (NASDAQ: BNTC ) BioCardia Inc (NASDAQ: BCDA ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Catabasis Pharmaceuticals Inc (NASDAQ: CATB ) Celsion Corporation (NASDAQ: CLSN ) Codiak BioSciences Inc (NASDAQ: CDAK ) Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX ) Entasis Therapeutics Holdings Inc (NASDAQ: ETTX ) FSD Pharma Inc (NASDAQ: HUGE ) Galecto Inc (NASDAQ: GLTO ) (went public Thursday) Hoth Therapeutics Inc (NASDAQ: HOTH ) Inhibrx Inc (NASDAQ: INBX ) Iterum Therapeutics PLC (NASDAQ: ITRM ) Jaguar Health Inc (NASDAQ: JAGX ) Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX ) Monopar Therapeutics Inc (NASDAQ: MNPR ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) Neovasc Inc (NASDAQ: NVCN ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) (halted dosing in Strimvelis study after it was linked to the development of leukemia in a patient) Orphazyme A S ADR (NASDAQ: ORPH ) Pliant Therapeutics Inc (NASDAQ: PLRX ) RA Medical Systems Inc (NYSE: RMED ) Recro Pharma Inc (NASDAQ: REPH ) Rockwell Medical Inc (NASDAQ: RMTI ) Teligent Inc (NEW JERSEY) (NASDAQ: TLGT ) Titan Pharmaceuticals, Inc. common stock (NASDAQ: TTNP ) Stocks In Focus Aurinia Ends Dry Eye Disease Study Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) said topline results from its Phase 2/3 AUDREY clinical study evaluating voclosporin ophthalmic solution for the potential treatment of …
関連キーワード （医薬品 米国株 ロックウェル・メディカル RMTI Rockwell Medical Inc.）